Chatterjee Saurav 4
4 · Augmedix, Inc. · Filed May 17, 2024
Insider Transaction Report
Form 4
Augmedix, Inc.AUGX
Chatterjee Saurav
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-15+4,688→ 4,688 total - Sale
Common Stock
2024-05-15$1.19/sh−1,767$2,103→ 2,921 total - Exercise/Conversion
Restricted Stock Units
2024-05-15−4,688→ 70,312 total→ Common Stock (4,688 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]Represents an original award of 75,000 RSUs to acquire shares of the Company's common stock. The RSU was granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. One-sixteenth (1/16th) of the RSU will vest quarterly in equal increments over four (4) years commencing on 02/15/2024, with the first one-sixteenth (1/16th) vesting on 5/15/2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.